[EN] HISTONE METHYLTRANSFERASE INHIBITORS<br/>[FR] INHIBITEURS DE L'HISTONE MÉTHYLTRANSFÉRASE
申请人:GLOBAL BLOOD THERAPEUTICS INC
公开号:WO2018119208A1
公开(公告)日:2018-06-28
The present disclosure provides certain angular tricyclic compounds that are histone methyltransi erases G9a and/or GLP inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of G9a and/or GLP such as cancers and hemoglobinpathies (e.g., beta- thalassemia and sickle cell disease). Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
本公开提供了一些角三环化合物,这些化合物是组蛋白甲基转移酶G9a和/或GLP的抑制剂,因此可用于治疗可以通过抑制G9a和/或GLP来治疗的疾病,例如癌症和血红蛋白病(例如,β-地中海贫血和镰状细胞病)。还提供了含有这些化合物的药物组合物以及制备这些化合物的方法。